Looking back
Biomarkers for the effects of cannabis and THC in healthy volunteers
Effect of naproxen on the hypothalamic–pituitary– adrenal axis in healthy volunteers
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment
4β-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin
Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa
A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers
The effects of melatonin on sleep–wake rhythm of daytime haemodialysis patients
Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients
Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents
Exposure to antibacterial agents with QT liability in 14 European countries
Effect of statins on a wide range of health outcomes
High-dose antipsychotic use in schizophrenia
The CADEUS study
Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications
Do thiazide diuretics alter the pharmacokinetics of metformin in patients with type 2 diabetes already established on metformin?
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction
Mirtazapine induced nightmares in an adult male
Suggestions for effective contraception in isotretinoin therapy
Biphasic creatine kinase elevation in pseudoephedrine overdosage
Investigator-initiated pragmatic trials in developing countries – much needed but much ignored
Translation Section